Mark A. Ellis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark A. Ellis has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Terry A. Day
Department of Otolaryngology–Head & Neck Surgery Medical University of South Carolina Charleston South Carolina U.S.A.
5 shared publications- Evan M. Graboyes
Department of Otolaryngology–Head and Neck Surgery Medical University of South Carolina Charleston South Carolina USA
4 shared publications Anand K. Sharma
Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina
2 shared publicationsDavid M. Neskey
Department of Otolaryngology-Head & Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
2 shared publicationsEric J. Lentsch
Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina
2 shared publicationsJohn M. Kaczmar
Division of Medical Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina
2 shared publications
Latest Publications
- 24 August 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (3) , E875-E881
Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function
Objective: To characterize pharyngocutaneous fistula (PCF) rates and functional outcomes following microvascular free tissue transfer (MVFTT) reconstruction of salvage total laryngectomy (STL) with a review of two different flap inset techniques and a review of the literature.Methods: Retrospective review.Results: Review of the literature revealed 887 patients who underwent STL MVFTT from 14 references. Ninety‐six STL MVFTTs were performed by the authors, with 36 (38%) patients undergoing multilayer fascial underlay (MLFU) closure and 60 (62%) a standard single layer closure (SLC). One (3%) PCF occurred in the MLFU group compared to 12 (20%) in the SLC cohort (P = .03). Postoperative gastrostomy (G)‐tube dependence was lower following MLFU closure compared to SLC (25% vs. 57%, P < .01), whereas pharyngoesophageal stricture (PES) (28% vs. 38%), tracheoesophageal puncture (TEP) placement (42% vs. 42%), and TEP usage (87% vs. 88%) did not significantly differ (P > .05). Compared to pooled rates from the literature, patients who underwent a MLFU MVFTT inset technique demonstrated significantly lower PCF incidence (3% vs. 23%, P < .01) without significant differences in PES (28% vs 23%, P = .55), G‐tube dependence (25% vs. 23%, P = .25), or TEP placement (42% vs. 59%, P = .09).Conclusion: Despite MVFTT reconstruction after STL, G‐tube dependence, PCF formation, and limitations of speaking rehabilitation (TEP) remain a significant issue. Modification of MVFTT inset may provide an opportunity to reduce PCF incidence without affecting other functional outcomes.Level of Evidence: 4 Laryngoscope, 131:E875–E881, 2021
- 24 August 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (3) , E875-E881
Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function
Objective: To characterize pharyngocutaneous fistula (PCF) rates and functional outcomes following microvascular free tissue transfer (MVFTT) reconstruction of salvage total laryngectomy (STL) with a review of two different flap inset techniques and a review of the literature.Methods: Retrospective review.Results: Review of the literature revealed 887 patients who underwent STL MVFTT from 14 references. Ninety‐six STL MVFTTs were performed by the authors, with 36 (38%) patients undergoing multilayer fascial underlay (MLFU) closure and 60 (62%) a standard single layer closure (SLC). One (3%) PCF occurred in the MLFU group compared to 12 (20%) in the SLC cohort (P = .03). Postoperative gastrostomy (G)‐tube dependence was lower following MLFU closure compared to SLC (25% vs. 57%, P < .01), whereas pharyngoesophageal stricture (PES) (28% vs. 38%), tracheoesophageal puncture (TEP) placement (42% vs. 42%), and TEP usage (87% vs. 88%) did not significantly differ (P > .05). Compared to pooled rates from the literature, patients who underwent a MLFU MVFTT inset technique demonstrated significantly lower PCF incidence (3% vs. 23%, P < .01) without significant differences in PES (28% vs 23%, P = .55), G‐tube dependence (25% vs. 23%, P = .25), or TEP placement (42% vs. 59%, P = .09).Conclusion: Despite MVFTT reconstruction after STL, G‐tube dependence, PCF formation, and limitations of speaking rehabilitation (TEP) remain a significant issue. Modification of MVFTT inset may provide an opportunity to reduce PCF incidence without affecting other functional outcomes.Level of Evidence: 4 Laryngoscope, 131:E875–E881, 2021
- 9 April 2019
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 161 (2) , 278-287
Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient‐Centered Approach
Objective: To promote patient‐centered oncology care through an in‐depth analysis of the patient experience of body image disturbance (BID) following surgery for head and neck cancer (HNC).Study Design: Qualitative methods approach using semistructured key informant interviews.Setting: Academic medical center.Subjects and Methods: Participants with surgically treated HNC underwent semistructured key informant interviews and completed a sociodemographic survey. Recorded interviews were transcribed, coded, and analyzed using template analysis to inform creation of a conceptual model.Results: Twenty‐two participants with surgically treated HNC were included, of whom 16 had advanced stage disease and 15 underwent free tissue transfer. Five key themes emerged characterizing the participants’ lived experiences with BID following HNC treatment: personal dissatisfaction with appearance, other‐oriented appearance concerns, appearance concealment, distress with functional impairments, and social avoidance. The participant’s perceived BID severity was modified by preoperative patient expectations, social support, and positive rational acceptance. These 5 key themes and 3 experiential modifiers form the basis of a novel, patient‐centered conceptual model for understanding BID in HNC survivors.Conclusion: A patient‐centered approach to HNC care reveals that dissatisfaction with appearance, other‐oriented appearance concerns, appearance concealment, distress with functional impairments, and social avoidance are key conceptual domains characterizing HNC‐related BID. Recognition of these psychosocial dimensions of BID in HNC patients can inform development of HNC‐specific BID patient‐reported outcome measures to facilitate quantitative assessment of BID as well as the development of novel preventative and therapeutic strategies for those at risk for, or suffering from, BID.
- 9 April 2019
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 161 (2) , 278-287
Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient‐Centered Approach
Objective: To promote patient‐centered oncology care through an in‐depth analysis of the patient experience of body image disturbance (BID) following surgery for head and neck cancer (HNC).Study Design: Qualitative methods approach using semistructured key informant interviews.Setting: Academic medical center.Subjects and Methods: Participants with surgically treated HNC underwent semistructured key informant interviews and completed a sociodemographic survey. Recorded interviews were transcribed, coded, and analyzed using template analysis to inform creation of a conceptual model.Results: Twenty‐two participants with surgically treated HNC were included, of whom 16 had advanced stage disease and 15 underwent free tissue transfer. Five key themes emerged characterizing the participants’ lived experiences with BID following HNC treatment: personal dissatisfaction with appearance, other‐oriented appearance concerns, appearance concealment, distress with functional impairments, and social avoidance. The participant’s perceived BID severity was modified by preoperative patient expectations, social support, and positive rational acceptance. These 5 key themes and 3 experiential modifiers form the basis of a novel, patient‐centered conceptual model for understanding BID in HNC survivors.Conclusion: A patient‐centered approach to HNC care reveals that dissatisfaction with appearance, other‐oriented appearance concerns, appearance concealment, distress with functional impairments, and social avoidance are key conceptual domains characterizing HNC‐related BID. Recognition of these psychosocial dimensions of BID in HNC patients can inform development of HNC‐specific BID patient‐reported outcome measures to facilitate quantitative assessment of BID as well as the development of novel preventative and therapeutic strategies for those at risk for, or suffering from, BID.
- Open Access
Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival
BACKGROUND: Patients who travel a long distance (≥50 miles) for cancer care have improved outcomes. However, to the authors' knowledge, the prevalence of long travel distances for treatment by patients with head and neck squamous cell carcinoma (HNSCC), and the effect of travel distance on overall survival (OS), remains unknown. METHODS: The authors used the National Cancer Data base from 2004 through 2013 to identify patients with HNSCC undergoing definitive treatment. Travel distance for treatment was categorized as short (P <.001). Traveling a long distance for treatment was associated with improved OS on multivariable analysis (adjusted hazard ratio, 0.93; 95% confidence interval, 0.89‐0.96) compared with a short distance. CONCLUSIONS: Traveling a long distance for HNSCC treatment is associated with improved survival, especially for patients receiving nonsurgical management. Racial and ethnic disparities in travel for HNSCC treatment exist. As regionalization of care continues, future work should identify and address reasons for racial and ethnic disparities in travel that may prevent access to care at high‐volume facilities. Cancer 2018;000:000‐000 . © 2018 American Cancer Society .
Open AccessRacial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival
BACKGROUND: Patients who travel a long distance (≥50 miles) for cancer care have improved outcomes. However, to the authors' knowledge, the prevalence of long travel distances for treatment by patients with head and neck squamous cell carcinoma (HNSCC), and the effect of travel distance on overall survival (OS), remains unknown. METHODS: The authors used the National Cancer Data base from 2004 through 2013 to identify patients with HNSCC undergoing definitive treatment. Travel distance for treatment was categorized as short (P <.001). Traveling a long distance for treatment was associated with improved OS on multivariable analysis (adjusted hazard ratio, 0.93; 95% confidence interval, 0.89‐0.96) compared with a short distance. CONCLUSIONS: Traveling a long distance for HNSCC treatment is associated with improved survival, especially for patients receiving nonsurgical management. Racial and ethnic disparities in travel for HNSCC treatment exist. As regionalization of care continues, future work should identify and address reasons for racial and ethnic disparities in travel that may prevent access to care at high‐volume facilities. Cancer 2018;000:000‐000 . © 2018 American Cancer Society .
- 19 December 2017
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 158 (4) , 649-659
Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer
Objective: The goal of this study is to determine the effect of primary surgery vs radiotherapy (RT) on overall survival (OS) in patients with early stage oral cavity squamous cell carcinoma (OCSCC). In addition, this study attempts to identify factors associated with receiving primary RT.Study Design: Retrospective cohort study.Setting: National Cancer Database (NCDB, 2004‐2013).Subjects and Methods: Reviewing the NCDB from 2004 to 2013, patients with early stage I to II OCSCC were identified. Kaplan‐Meier estimates of survival, Cox regression analysis, and propensity score matching were used to examine differences in OS between primary surgery and primary RT. Multivariable logistic regression analysis was performed to identify factors associated with primary RT.Results: Of the 20,779 patients included in the study, 95.4% (19,823 patients) underwent primary surgery and 4.6% (956 patients) underwent primary RT. After adjusting for covariates, primary RT was associated with an increased risk of mortality (adjusted hazard ratio [aHR], 1.97; 99% confidence interval [CI], 1.74‐2.22). On multivariable analysis, factors associated with primary RT included age ≥70 years, black race, Medicaid or Medicare insurance, no insurance, oral cavity subsite other than tongue, clinical stage II disease, low‐volume treatment facilities, and earlier treatment year.Conclusion: Primary RT for early stage OCSCC is associated with increased mortality. Approximately 5% of patients receive primary RT; however, this percentage is decreasing. Patients at highest risk for receiving primary RT include those who are elderly, black, with public insurance, and treated at low‐volume facilities.
- 19 December 2017
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 158 (4) , 649-659
Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer
Objective: The goal of this study is to determine the effect of primary surgery vs radiotherapy (RT) on overall survival (OS) in patients with early stage oral cavity squamous cell carcinoma (OCSCC). In addition, this study attempts to identify factors associated with receiving primary RT.Study Design: Retrospective cohort study.Setting: National Cancer Database (NCDB, 2004‐2013).Subjects and Methods: Reviewing the NCDB from 2004 to 2013, patients with early stage I to II OCSCC were identified. Kaplan‐Meier estimates of survival, Cox regression analysis, and propensity score matching were used to examine differences in OS between primary surgery and primary RT. Multivariable logistic regression analysis was performed to identify factors associated with primary RT.Results: Of the 20,779 patients included in the study, 95.4% (19,823 patients) underwent primary surgery and 4.6% (956 patients) underwent primary RT. After adjusting for covariates, primary RT was associated with an increased risk of mortality (adjusted hazard ratio [aHR], 1.97; 99% confidence interval [CI], 1.74‐2.22). On multivariable analysis, factors associated with primary RT included age ≥70 years, black race, Medicaid or Medicare insurance, no insurance, oral cavity subsite other than tongue, clinical stage II disease, low‐volume treatment facilities, and earlier treatment year.Conclusion: Primary RT for early stage OCSCC is associated with increased mortality. Approximately 5% of patients receive primary RT; however, this percentage is decreasing. Patients at highest risk for receiving primary RT include those who are elderly, black, with public insurance, and treated at low‐volume facilities.
- 1 September 2017
- Published by Elsevier in Oral Oncology
- Vol. 72, 174-178
Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database
- 1 September 2017
- Published by Elsevier in Oral Oncology
- Vol. 72, 174-178
Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database
- Open Access
- 5 January 2017
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 126 (3) , 179-184
Ewing Sarcoma of the Head and Neck
Ewing sarcoma is a rare tumor of the head and neck. Previous efforts to characterize Ewing sarcoma of the head and neck (ES-HN) have been limited to small retrospective series. The objective of this study was to analyze the demographic, clinicopathologic, treatment, and survival characteristics of ES-HN compared to Ewing sarcoma at other locations (ES-other). Using the Surveillance, Epidemiology, and End Results (SEER) database, we compared 183 patients with ES-HN to 3177 patients with ES-other. Patient characteristics were analyzed with chi-square or t test. Ten-year disease-specific survival (DSS) and overall survival (OS) were estimated via the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to determine if HN location was an independent prognosticator. The ES-HN displayed a lower tumor size (P < .001) and metastatic rate (P < .001) compared to ES-other. The ES-HN had a better 10-year DSS and OS than ES-other (P = .001, P = .015, respectively). The HN location did not achieve statistical significance on multivariate Cox regression analysis (P = .88). ES-HN does not appear to be a separate clinical entity compared to ES-other; rather, its associated improved prognosis is likely secondary to its smaller size and lower metastatic rate compared to ES-other.
- 5 January 2017
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 126 (3) , 179-184
Open AccessEwing Sarcoma of the Head and Neck
Ewing sarcoma is a rare tumor of the head and neck. Previous efforts to characterize Ewing sarcoma of the head and neck (ES-HN) have been limited to small retrospective series. The objective of this study was to analyze the demographic, clinicopathologic, treatment, and survival characteristics of ES-HN compared to Ewing sarcoma at other locations (ES-other). Using the Surveillance, Epidemiology, and End Results (SEER) database, we compared 183 patients with ES-HN to 3177 patients with ES-other. Patient characteristics were analyzed with chi-square or t test. Ten-year disease-specific survival (DSS) and overall survival (OS) were estimated via the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to determine if HN location was an independent prognosticator. The ES-HN displayed a lower tumor size (P < .001) and metastatic rate (P < .001) compared to ES-other. The ES-HN had a better 10-year DSS and OS than ES-other (P = .001, P = .015, respectively). The HN location did not achieve statistical significance on multivariate Cox regression analysis (P = .88). ES-HN does not appear to be a separate clinical entity compared to ES-other; rather, its associated improved prognosis is likely secondary to its smaller size and lower metastatic rate compared to ES-other.
- 4 April 2016
- Published by Wiley in Head & Neck
- Vol. 38 (9) , 1359-1366
Head and neck chondrosarcomas: Analysis of the Surveillance, Epidemiology, and End Results database
Background: Chondrosarcoma is a rare tumor of the head and neck. Because of the limited clinical data, no studies have conducted a thorough comparison between head and neck chondrosarcomas and those arising at other body sites.Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we compared 682 patients with chondrosarcomas of the head and neck with 4757 patients with non–head and neck chondrosarcomas, evaluating disease‐specific survival (DSS) and overall survival (OS) based on tumor location, histology, grade, stage, and treatment.Results: Head and neck chondrosarcomas displayed a lower grade (p < .001) and stage (p < .0001) compared with other chondrosarcomas. Overall, chondrosarcomas of the head and neck had significantly higher DSS and OS than non–head and neck chondrosarcomas (p < .001).Conclusion: Chondrosarcomas of the head and neck display a lower grade and stage compared with other chondrosarcomas. DSS and OS were significantly greater for chondrosarcomas of the head and neck. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1359–1366, 2016
- 4 April 2016
- Published by Wiley in Head & Neck
- Vol. 38 (9) , 1359-1366
Head and neck chondrosarcomas: Analysis of the Surveillance, Epidemiology, and End Results database
Background: Chondrosarcoma is a rare tumor of the head and neck. Because of the limited clinical data, no studies have conducted a thorough comparison between head and neck chondrosarcomas and those arising at other body sites.Methods: Using the Surveillance, Epidemiology, and End Results (SEER) database, we compared 682 patients with chondrosarcomas of the head and neck with 4757 patients with non–head and neck chondrosarcomas, evaluating disease‐specific survival (DSS) and overall survival (OS) based on tumor location, histology, grade, stage, and treatment.Results: Head and neck chondrosarcomas displayed a lower grade (p < .001) and stage (p < .0001) compared with other chondrosarcomas. Overall, chondrosarcomas of the head and neck had significantly higher DSS and OS than non–head and neck chondrosarcomas (p < .001).Conclusion: Chondrosarcomas of the head and neck display a lower grade and stage compared with other chondrosarcomas. DSS and OS were significantly greater for chondrosarcomas of the head and neck. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1359–1366, 2016